|5 |6 |7 |8 |9 |10 |11 |12 |13 |14 |15 |16 |17 |18 |19 |20 |21 |22 |23 |24 |25 |26 |27 |28 |29 |30 |31 |32 |33 |34 |35 |36 |37 |38 |39 |40 |review Key Point: In the STELLAR trial, rosuvastatin established and maintained increased HDL-C with every dose, while ...
|3 |4 |5 |6 |7 |8 |9 |10 |11 |12 |13 |14 |15 |16 |17 |18 |19 |20 |21 |22 |23 |24 |25 |26 |27 |28 |29 |30 |31 |32 |33 |34 |35|36 |37 |38 |39 |40 |review Key Point: After 6 weeks of treatment in the STELLAR trial, a significantly greater percentage of patients treated with ...
![Efficacy of rosuvastatin compared with other statins at selected starting doses in hypercholesterolemic patients and in special population groups - American Journal of Cardiology Efficacy of rosuvastatin compared with other statins at selected starting doses in hypercholesterolemic patients and in special population groups - American Journal of Cardiology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/5cbf2f81-81fc-4914-a940-ad434af41a63/gr1.gif)
Efficacy of rosuvastatin compared with other statins at selected starting doses in hypercholesterolemic patients and in special population groups - American Journal of Cardiology
![Effect of atorvastatin versus rosuvastatin on inflammatory biomarkers and LV function in type 2 diabetic patients with dyslipidemia - ScienceDirect Effect of atorvastatin versus rosuvastatin on inflammatory biomarkers and LV function in type 2 diabetic patients with dyslipidemia - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S075333222031372X-ga1.jpg)
Effect of atorvastatin versus rosuvastatin on inflammatory biomarkers and LV function in type 2 diabetic patients with dyslipidemia - ScienceDirect
|2 |3 |4 |5 |6 |7 |8 |9 |10 |11 |12 |13 |14 |15 |16 |17 |18 |19 |20 |21 |22 |23 |24 |25 |26 |27 |28 |29 |30 |31 |32 |33 |34 |35 |36 |37 |38 |39 |40 |review Key Point: In the STELLAR trial, the 10-mg dose of rosuvastatin lowered LDL-C more effectively than atorvastatin ...
![Comparison of the efficacy and safety of rosuvastatin versus atorvastatin in reduction of low density lipoprotein cholesterol in patients of type 2 diabetes mellitus with dyslipidemia | Semantic Scholar Comparison of the efficacy and safety of rosuvastatin versus atorvastatin in reduction of low density lipoprotein cholesterol in patients of type 2 diabetes mellitus with dyslipidemia | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/b6d5b5912f98294aa4a4ccfa1d64a883babac4f4/3-Figure1-1.png)
Comparison of the efficacy and safety of rosuvastatin versus atorvastatin in reduction of low density lipoprotein cholesterol in patients of type 2 diabetes mellitus with dyslipidemia | Semantic Scholar
![a) Rosuvastatin versus other statins, (b) Comparison of patients with... | Download Scientific Diagram a) Rosuvastatin versus other statins, (b) Comparison of patients with... | Download Scientific Diagram](https://www.researchgate.net/profile/Abdulbari-Bener/publication/260169709/figure/fig1/AS:614182156267543@1523443845441/a-Rosuvastatin-versus-other-statins-b-Comparison-of-patients-with-pre-and.png)
a) Rosuvastatin versus other statins, (b) Comparison of patients with... | Download Scientific Diagram
![Ezetimibe/statin combination therapy more effective in LDL-c lowering than statin uptitration - PACE-CME Ezetimibe/statin combination therapy more effective in LDL-c lowering than statin uptitration - PACE-CME](https://pace-cme.org/2013/11/26/ezetimibe-statin-combination-therapy-more-effective-in-ldl-c-lowering-than-statin-uptitration/images/Ezetimibe-statin-combination-therapy-more-effective-in-LDL-c-lowering-than-statin-uptitration-2x.png)
Ezetimibe/statin combination therapy more effective in LDL-c lowering than statin uptitration - PACE-CME
![Comparison of Efficacy and Safety of Rosuvastatin, Atorvastatin and Pravastatin among Dyslipidemic Diabetic Patients Comparison of Efficacy and Safety of Rosuvastatin, Atorvastatin and Pravastatin among Dyslipidemic Diabetic Patients](https://static-01.hindawi.com/articles/isrn/volume-2013/146579/figures/146579.fig.001.jpg)
Comparison of Efficacy and Safety of Rosuvastatin, Atorvastatin and Pravastatin among Dyslipidemic Diabetic Patients
![Figure 58 from Efficacy and safety of rosuvastatin vs. atorvastatin in lowering LDL cholesterol | Semantic Scholar Figure 58 from Efficacy and safety of rosuvastatin vs. atorvastatin in lowering LDL cholesterol | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/4233f4c81ae1eafc84d15a88e81847590b6349ed/4-Table2-1.png)
Figure 58 from Efficacy and safety of rosuvastatin vs. atorvastatin in lowering LDL cholesterol | Semantic Scholar
![Comparison of Efficacy and Safety of Rosuvastatin, Atorvastatin and Pravastatin among Dyslipidemic Diabetic Patients Comparison of Efficacy and Safety of Rosuvastatin, Atorvastatin and Pravastatin among Dyslipidemic Diabetic Patients](https://static-01.hindawi.com/articles/isrn/volume-2013/146579/figures/146579.fig.003.jpg)
Comparison of Efficacy and Safety of Rosuvastatin, Atorvastatin and Pravastatin among Dyslipidemic Diabetic Patients
![Preferred dosages of atorvastatin and rosuvastatin for ascVD and DM... | Download Scientific Diagram Preferred dosages of atorvastatin and rosuvastatin for ascVD and DM... | Download Scientific Diagram](https://www.researchgate.net/profile/David-Waters-3/publication/278793426/figure/fig2/AS:391845004759051@1470434537710/Preferred-dosages-of-atorvastatin-and-rosuvastatin-for-ascVD-and-DM-management-Notes.png)
Preferred dosages of atorvastatin and rosuvastatin for ascVD and DM... | Download Scientific Diagram
![Efficacy, safety and effect on biomarkers related to cholesterol and lipoprotein metabolism of rosuvastatin 10 or 20 mg plus ezetimibe 10 mg vs. simvastatin 40 or 80 mg plus ezetimibe 10 mg Efficacy, safety and effect on biomarkers related to cholesterol and lipoprotein metabolism of rosuvastatin 10 or 20 mg plus ezetimibe 10 mg vs. simvastatin 40 or 80 mg plus ezetimibe 10 mg](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/6a2d30c7-9c77-4b5b-9d83-009bb8831a1a/gr1_lrg.jpg)
Efficacy, safety and effect on biomarkers related to cholesterol and lipoprotein metabolism of rosuvastatin 10 or 20 mg plus ezetimibe 10 mg vs. simvastatin 40 or 80 mg plus ezetimibe 10 mg
![Comparison of Efficacy and Safety of Rosuvastatin, Atorvastatin and Pravastatin among Dyslipidemic Diabetic Patients Comparison of Efficacy and Safety of Rosuvastatin, Atorvastatin and Pravastatin among Dyslipidemic Diabetic Patients](https://static-01.hindawi.com/articles/isrn/volume-2013/146579/figures/146579.fig.002.jpg)